Literature DB >> 19059387

Expression of monocyte chemoattractant protein-1 in rat dorsal root ganglia and spinal cord in experimental models of neuropathic pain.

Sang-Min Jeon1, Kyung-Min Lee, Hee-Jung Cho.   

Abstract

In this study, we evaluated the expression of MCP-1 in the rat dorsal root ganglion (DRG) and spinal cord following axotomy and chronic constriction injury (CCI) of the sciatic nerve and L5 spinal nerve ligation (L5 SNL) using an immunohistochemical approach. MCP-1 expression in the DRG peaked and declined before the full onset of pain hypersensitivity following nerve injury. Spinal expression of MCP-1 peaked when mechanical allodynia was maximal, but then declined rapidly despite the remarkable persistence of mechanical allodynia. The results suggest that MCP-1 may participate in the initiation of neuropathic pain, rather than in its maintenance. Despite increased MCP-1 in small and large DRG neurons, a remarkable increase in MCP-1-IR terminals was observed in the spinal superficial laminae following CCI and L5SNL, but not following axotomy; however, in the deeper laminae, a considerable increase in MCP-1-IR terminals, which may originate from the large and injured L5 DRG neurons, was found after L5 SNL. Our results demonstrate that MCP-1 synthesized in DRG neurons may or may not be transported to the spinal cord depending on the type of peripheral nerve injury. Additionally, increased MCP-1 in both intact L4 and injured L5 DRG neurons may contribute to neuropathic pain hypersensitivity following L5 SNL.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19059387     DOI: 10.1016/j.brainres.2008.11.046

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  24 in total

Review 1.  Chemokines, neuronal-glial interactions, and central processing of neuropathic pain.

Authors:  Yong-Jing Gao; Ru-Rong Ji
Journal:  Pharmacol Ther       Date:  2010-02-01       Impact factor: 12.310

2.  Role of lipocalin-2-chemokine axis in the development of neuropathic pain following peripheral nerve injury.

Authors:  Sangmin Jeon; Mithilesh Kumar Jha; Jiyeon Ock; Jungwan Seo; Myungwon Jin; Heejung Cho; Won-Ha Lee; Kyoungho Suk
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

3.  Sciatic nerve injury induces functional pro-nociceptive chemokine receptors in bladder-associated primary afferent neurons in the rat.

Authors:  R Foster; J Jung; A Farooq; C McClung; M S Ripsch; M P Fitzgerald; F A White
Journal:  Neuroscience       Date:  2011-03-30       Impact factor: 3.590

4.  Thrombospondin-4 contributes to spinal sensitization and neuropathic pain states.

Authors:  Doo-Sik Kim; Kang-Wu Li; Amin Boroujerdi; Yanhui Peter Yu; Chun-Yi Zhou; Ping Deng; John Park; Xia Zhang; Joshua Lee; Michael Corpe; Kelli Sharp; Oswald Steward; Cagla Eroglu; Ben Barres; Frank Zaucke; Zao C Xu; Z David Luo
Journal:  J Neurosci       Date:  2012-06-27       Impact factor: 6.167

5.  Systemic administration of an alpha-7 nicotinic acetylcholine agonist reverses neuropathic pain in male Sprague Dawley rats.

Authors:  Lisa C Loram; Frederick R Taylor; Keith A Strand; Steven F Maier; Jason D Speake; Kristen G Jordan; John W James; Steven P Wene; Robert C Pritchard; Heather Green; Katherine Van Dyke; Anatoly Mazarov; Sharon R Letchworth; Linda R Watkins
Journal:  J Pain       Date:  2012-12       Impact factor: 5.820

6.  Blocking spinal CCR2 with AZ889 reversed hyperalgesia in a model of neuropathic pain.

Authors:  Alexandre Serrano; Michel Paré; Fraser McIntosh; Steven J R Elmes; Giovanni Martino; Claudia Jomphe; Etienne Lessard; Paola M C Lembo; François Vaillancourt; Martin N Perkins; Chang Qing Cao
Journal:  Mol Pain       Date:  2010-12-10       Impact factor: 3.395

7.  Ablation of rat TRPV1-expressing Adelta/C-fibers with resiniferatoxin: analysis of withdrawal behaviors, recovery of function and molecular correlates.

Authors:  Kendall Mitchell; Brian D Bates; Jason M Keller; Matthew Lopez; Lindsey Scholl; Julia Navarro; Nicholas Madian; Gal Haspel; Michael I Nemenov; Michael J Iadarola
Journal:  Mol Pain       Date:  2010-12-17       Impact factor: 3.395

8.  Increased chemokine signaling in a model of HIV1-associated peripheral neuropathy.

Authors:  Sonia K Bhangoo; Matthew S Ripsch; David J Buchanan; Richard J Miller; Fletcher A White
Journal:  Mol Pain       Date:  2009-08-12       Impact factor: 3.395

9.  Blockers of Wnt3a, Wnt10a, or β-Catenin Prevent Chemotherapy-Induced Neuropathic Pain In Vivo.

Authors:  Hee Kee Kim; Jingi Bae; Sung Ho Lee; Seon-Hee Hwang; Min-Sik Kim; Moon Jong Kim; Sohee Jun; Chris L Cervantes; Youn-Sang Jung; Seunghoon Back; Hangyeore Lee; Seung-Eun Lee; Patrick M Dougherty; Sang-Won Lee; Jae-Il Park; Salahadin Abdi
Journal:  Neurotherapeutics       Date:  2020-10-30       Impact factor: 7.620

10.  Targeting anti-inflammatory treatment can ameliorate injury-induced neuropathic pain.

Authors:  Katsuyuki Iwatsuki; Tetsuya Arai; Hideyuki Ota; Shuichi Kato; Tadahiro Natsume; Shigeru Kurimoto; Michiro Yamamoto; Hitoshi Hirata
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.